120 related articles for article (PubMed ID: 2697413)
1. Allogeneic BMT for AML in Zagreb.
Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
[No Abstract] [Full Text] [Related]
2. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
[No Abstract] [Full Text] [Related]
3. Allogeneic bone marrow transplantation for ALL in Zagreb.
Bogdanić V; Labar B; Nemet D; Mrsić M; Pavetić Z; Aurer I
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():88-9. PubMed ID: 2697414
[No Abstract] [Full Text] [Related]
4. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.
Zittoun R; Mandelli F; De Witte T; Willemze R; Tura S
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():56-8. PubMed ID: 2202470
[No Abstract] [Full Text] [Related]
5. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
[No Abstract] [Full Text] [Related]
7. Post remission therapy in acute myeloid leukaemia (AML): the Medical Research Council experience in the UK.
Rees JK; Gray RG
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():70-1. PubMed ID: 2697405
[No Abstract] [Full Text] [Related]
8. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
Szer J; Grigg AP; Phillips GL; Sheridan WP
Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
[TBL] [Abstract][Full Text] [Related]
9. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
11. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
Bone Marrow Transplant; 1991; 7 Suppl 2():9-10. PubMed ID: 1878737
[No Abstract] [Full Text] [Related]
12. Autologous BMT for AML without purging.
Burnett AK
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():76-8. PubMed ID: 2697408
[No Abstract] [Full Text] [Related]
13. Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
Vowels M; Stevens M; Tiedemann K; Brown R
Transplant Proc; 1992 Feb; 24(1):184-5. PubMed ID: 1539237
[No Abstract] [Full Text] [Related]
14. Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
Kapoor N; Copelan EA; Klein J; Tutschka PJ
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():153-5. PubMed ID: 2697430
[No Abstract] [Full Text] [Related]
15. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
16. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intensive consolidation therapy and autologous bone marrow transplantation in acute myeloid leukaemia. The Leiden experience.
Willemze R; Fibbe WE; Richel DJ; Kluin-Nelemans JC; Zwaan FE
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():73. PubMed ID: 2697407
[No Abstract] [Full Text] [Related]
18. [Allogeneic bone marrow transplantation in acute myeloid leukemia (AML): results in 14 patients].
Kos M; Hinterberger W; Gadner H; Haas O; Kalhs P; Panzer S; Geissler K; Schwarzinger I; Hinterberger-Fischer M; Neumann E
Wien Klin Wochenschr; 1987 Apr; 99(7):217-22. PubMed ID: 3296468
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia and the position of autologous stem cell transplantation.
Breems DA; Löwenberg B
Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
[TBL] [Abstract][Full Text] [Related]
20. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
